Susan M. Burks

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

General Health Scientist

NCTR

Also affiliated: United States Food and Drug Administration (2013–2022)

10 h-index 16 pubs 623 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Susan M. Burks' research focuses on mechanisms of neurotoxicity and neurodegeneration, with recent investigations into the potential impact of SARS-CoV-2 on the central nervous system. She has explored whether the virus can infect the brain via the olfactory bulb or the blood-brain barrier, and has studied its potential to cause dopaminergic degeneration in human neuronal models. Her work also includes the evaluation of circulating biomarkers for neurotoxicity, using proteomics to identify endpoints of central nervous system toxicity in rodent models. Additionally, Burks has conducted genotoxicity evaluations using primary hepatocytes isolated from rhesus macaques. Her research network includes collaborators such as John Talpos and Manuel Alejandro Ramirez-Lee from the National Center for Toxicological Research. Burks' scholarly output includes 10 publications, with an h-index of 7 and 327 total citations.

Metrics

h-index: 10
Publications: 16
Citations: 623

Positions

General Health Scientist 2008–present

National Center for Toxicological Research Office of Research ORCID

Selected Publications

Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model (2022)

Toxicology Reports 2 citations DOI OpenAlex
Circulating biomarkers of neurotoxicity: Proteomics approach reveals fluidic endpoints of central nervous system toxicity in a rodent model of neurotoxicity (2021)

Journal of Pharmacological and Toxicological Methods DOI OpenAlex
Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta) (2021)

Toxicology 6 citations DOI OpenAlex
Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? (2021)

Brain Behavior and Immunity 103 citations DOI OpenAlex
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease (2020)

Nutritional Neuroscience 58 citations DOI OpenAlex
Regions of the basal ganglia and primary olfactory system are most sensitive to neurodegeneration after extended sevoflurane anesthesia in the perinatal rat (2020)

Neurotoxicology and Teratology 8 citations DOI OpenAlex
Microglial activation and responses to vasculature that result from an acute LPS exposure (2020)

NeuroToxicology 52 citations DOI OpenAlex
Stretch-Induced Deformation as a Model to Study Dopaminergic Dysfunction in Traumatic Brain Injury (2019)

Neurochemical Research 11 citations DOI OpenAlex
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro (2019)

Metabolic Brain Disease 57 citations DOI OpenAlex
Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson’s disease mouse model: Endothelial and microglial effects (2019)

Neuroscience Letters 37 citations DOI OpenAlex